These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 12365879)

  • 1. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.
    McGorry PD; Yung AR; Phillips LJ; Yuen HP; Francey S; Cosgrave EM; Germano D; Bravin J; McDonald T; Blair A; Adlard S; Jackson H
    Arch Gen Psychiatry; 2002 Oct; 59(10):921-8. PubMed ID: 12365879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
    Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
    JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.
    Yung AR; Phillips LJ; Nelson B; Francey SM; PanYuen H; Simmons MB; Ross ML; Kelly D; Baker K; Amminger GP; Berger G; Thompson AD; Thampi A; McGorry PD
    J Clin Psychiatry; 2011 Apr; 72(4):430-40. PubMed ID: 21034687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.
    McGorry PD; Nelson B; Phillips LJ; Yuen HP; Francey SM; Thampi A; Berger GE; Amminger GP; Simmons MB; Kelly D; Dip G; Thompson AD; Yung AR
    J Clin Psychiatry; 2013 Apr; 74(4):349-56. PubMed ID: 23218022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring and care of young people at incipient risk of psychosis.
    Yung AR; McGorry PD; McFarlane CA; Jackson HJ; Patton GC; Rakkar A
    Schizophr Bull; 1996; 22(2):283-303. PubMed ID: 8782287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.
    Langer ÁI; Schmidt C; Mayol R; Díaz M; Lecaros J; Krogh E; Pardow A; Vergara C; Vergara G; Pérez-Herrera B; Villar MJ; Maturana A; Gaspar PA
    Trials; 2017 May; 18(1):233. PubMed ID: 28545578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Intervention for psychosis.
    Marshall M; Lockwood A
    Cochrane Database Syst Rev; 2004; (2):CD004718. PubMed ID: 15106257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
    Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
    Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: results after one year.
    Sanz-Fuentenebro J; Taboada D; Palomo T; Aragües M; Ovejero S; Del Alamo C; Molina V
    Schizophr Res; 2013 Sep; 149(1-3):156-61. PubMed ID: 23870807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
    Marder SR; Glynn SM; Wirshing WC; Wirshing DA; Ross D; Widmark C; Mintz J; Liberman RP; Blair KE
    Am J Psychiatry; 2003 Aug; 160(8):1405-12. PubMed ID: 12900301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Gee D; Crisp K; Pearce T; Newman B; Spiliotacopoulos D; Castle D; McGorry PD
    J Clin Psychiatry; 2009 Apr; 70(4):477-86. PubMed ID: 19323964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study.
    Liu Y; Yang X; Gillespie A; Guo Z; Ma Y; Chen R; Li Z
    Psychiatry Res; 2019 Feb; 272():275-283. PubMed ID: 30594760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.